InMed Pharmaceuticals (INM) Exchange Rate Effect (2019 - 2020)
InMed Pharmaceuticals (INM) posted quarterly Exchange Rate Effect of $367235.0 for Q4 2020, up 62.07% year-over-year from $226587.0 in Q1 2020, and up 187.52% quarter-over-quarter from $127725.0 in Q3 2020.
InMed Pharmaceuticals (INM) Exchange Rate Effect (2019 - 2020) Analysis & Trends
InMed Pharmaceuticals' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $367235.0 for Q4 2020.
- In Q4 2020, Exchange Rate Effect rose 62.07% year-over-year to $367235.0; the TTM figure through Jun 2021 stood at $494960.0 (up 218.88% YoY), while the FY2021 annual figure was $494960.0, up 218.88% from the prior year.
- Exchange Rate Effect for Q4 2020 stood at $367235.0, up from $127725.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $367235.0 in Q4 2020, with the low at -$700247.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 367,235.00 |
| Dec 31, 2020 | 367,235.00 |
| Sep 30, 2020 | 127,725.00 |
| Sep 30, 2020 | 127,725.00 |
| Jun 30, 2020 | 265,857.00 |
| Jun 30, 2020 | 265,857.00 |
| Mar 31, 2020 | -700,247.00 |
| Mar 31, 2020 | -700,247.00 |
| Dec 31, 2019 | 226,587.00 |
| Dec 31, 2019 | 226,587.00 |
| Sep 30, 2019 | -208,550.00 |
| Sep 30, 2019 | -208,550.00 |